Lipid Nanoparticle and Liposome Characterization with FFF-MALS-DLS

W H I T E PA P E R WP2611: Characterization of nanopharmaceuticals with field-flow fractionation and light scattering (FFF-MALS-DLS) Dan Some, Ph.D., and Christoph Johann, Ph.D., Waters | Wyatt Technology Introduction One of the primary challenges in developing effective…

W H I T E PA P E R WP2612: Meeting regulatory needs in the characterization of lipid nanoparticles (LNPs) for RNA delivery via FFF-MALS Fanny Caputo, Ph.D., SINTEF Industry and Christian Sieg, Ph.D., Waters | Wyatt Technology Abstract Field-flow…

AN2615: Multi-attribute quantification of LNP-mRNA therapeutics by FFF-MALS and DLS Martin Kurnik, Ph.D., Wyatt Technology, LLC Summary Introduction Bringing effective and safe lipid nanoparticle-formulated mRNA therapeutics to market requires quantitation of multiple quality attributes throughout development, manufacturing, and quality control.…

P U B L I C AT I O N L I S T PL2609: Key publications on the characterization of nanoparticle drug and gene delivery systems by FFF-MALS-DLS Summary • This document lists key publications using AF4- MALS-DLS for…